XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 76,127 $ 68,802
Marketable securities, current 294,894 162,073
Accounts receivable 1,702 80,150
Related party collaboration receivable 1,549 3,341
Prepaid expenses and other current assets 7,298 5,318
Total current assets 381,570 319,684
Property and equipment, net 16,267 16,494
Deposits and other non-current assets 2,874 1,593
Operating lease, right-of-use assets 35,514 13,510
Total assets 436,225 351,281
Current liabilities:    
Accounts payable 2,605 1,604
Accrued expenses 10,273 16,823
Other current liabilities 6,736 3,200
Deferred revenue, current 20,516 42,881
Total current liabilities 40,130 64,508
Deferred revenue, non-current 19,473 32,359
Other non-current liabilities 41,205 18,094
Total liabilities 100,808 114,961
Commitments and contingencies (see note 7)
Stockholders' equity:    
Preferred stock, $0.001 par value: 5,000,000 shares authorized at June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023
Common stock, $0.001 par value: 120,000,000 shares authorized at June 30, 2024 and December 31, 2023; 54,472,113 and 44,038,333 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 54 44
Additional paid-in capital 618,538 497,506
Accumulated other comprehensive loss (522) (48)
Accumulated deficit (282,653) (261,182)
Total stockholders' equity 335,417 236,320
Total liabilities and stockholders' equity $ 436,225 $ 351,281